Achillion shares fall on concerns over hep C drug's future
(Reuters) - Achillion Pharmaceuticals' shares fell 12 percent on Friday, shedding some of their recent gains amid concerns raised by an investment website on the future of the company's key...
No comments:
Post a Comment